title: Active immunization of metastatic melanoma patients with interleukin-4 transduced, allogeneic melanoma cells. A phase I-II study.
authors.affiliation: Istituto Nazionale Tumori-Milano.
authors.forename: N
authors.initials: N
authors.lastname: Cascinelli
authors.forename: R
authors.initials: R
authors.lastname: Foà
authors.forename: G
authors.initials: G
authors.lastname: Parmiani
authors.forename: F
authors.initials: F
authors.lastname: Arienti
authors.forename: F
authors.initials: F
authors.lastname: Belli
authors.forename: M G
authors.initials: MG
authors.lastname: Bernengo
authors.forename: C
authors.initials: C
authors.lastname: Clemente
authors.forename: M P
authors.initials: MP
authors.lastname: Colombo
authors.forename: A
authors.initials: A
authors.lastname: Guarini
authors.forename: M T
authors.initials: MT
authors.lastname: Illeni
mesh_terms: D000818:Animals; D002985:Clinical Protocols; D018014:Gene Transfer Techniques; D015316:Genetic Therapy; D006801:Humans; D015847:Interleukin-4 / Q000008:administration & dosage / Q000235:genetics / Q000276:immunology / Q000627:therapeutic use*; D008545:Melanoma / Q000276:immunology / Q000628:therapy*; D051379:Mice; D014407:Tumor Cells, Cultured / Q000276:immunology / Q000637:transplantation; D014611:Vaccination
chemical_list: D015847:Interleukin-4